GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotron Ltd (OTCPK:BITRF) » Definitions » YoY Rev. per Sh. Growth

BITRF (Biotron) YoY Rev. per Sh. Growth : 0.00% (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Biotron YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Biotron's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 was 0.00%.

Biotron's Revenue per Share for the six months ended in Dec. 2024 was $0.00.

Biotron YoY Rev. per Sh. Growth Historical Data

The historical data trend for Biotron's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotron YoY Rev. per Sh. Growth Chart

Biotron Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biotron Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biotron YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Biotron's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Jun. 2024 )
=(Revenue per Share (A: Jun. 2024 )-Revenue per Share (A: Jun. 2023 ))/ | Revenue per Share (A: Jun. 2023 ) |
=(0-0)/ | 0 |
=N/A %

Biotron's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2024 )
=(Revenue per Share (Q: Dec. 2024 )-Revenue per Share (Q: Dec. 2023 )) / | Revenue per Share (Q: Dec. 2023 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotron YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Biotron's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotron Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotron Ltd (OTCPK:BITRF) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
ASX:1AD ASX:ZLD ASX:VBS ASX:BGT ASX:IXC ASX:CMB ASX:PAB ASX:ANR ASX:NSB ASX:CHM VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
BIT:Australia
Address
56 Delhi Road, Suite 3.3, North Ryde, Sydney, NSW, AUS, 2113
Website
https://www.biotron.com.au
Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Biotron Headlines

From GuruFocus

Biotron Drug Effective Against COVID-19 In Animals

By PRNewswire PRNewswire • 11-25-2021